Assessment of Posttransplant Bacteremia Caused by Extended‐Spectrum Beta‐Lactamase–Producing Gram‐Negative Bacteria Among Kidney Transplant Recipients
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15390 ↗At a glance
Journal article in Clinical Transplantation, 2024. Written by Madeleine S Tilley and 6 co-authors. Institution: Department of Pharmacy, University of Alabama at Birmingham, Birmingham, USA. Major MEDLINE topics: Kidney Transplantation, Bacteremia, beta-Lactamases, Gram-Negative Bacterial Infections. Cited 5 times so far (Crossref); 15 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background
Extended‐spectrum beta‐lactamase–producing gram‐negative rods (ESBL‐GNR) are a rising cause of bacteremia in kidney transplant recipients (KT). The study purpose was to examine patient mortality, allograft survival, estimated glomerular filtration rate (eGFR) at the end of 1 year, and readmission rates while looking at treatment strategies among KTs with ESBL‐GNR and non–ESBL‐GNR bacteremia at our institution.
Methods
This study was a retrospective, cohort analysis of KTs with gram‐negative bacteremia from January 1, 2020, to December 31, 2021. The primary outcome of the study was mortality. Patient outcomes were assessed for 365 days after positive blood cultures.
Results
The study included 63 patients. Of these, 18 (29%) patients had bacteremia caused by an ESBL‐GNR and 45 (71%) patients had bacteremia caused by a non–ESBL‐GNR. Patient survival at 90 days was 94% in the ESBL‐GNR group and 96% in the non–ESBL‐GNR group. Ciprofloxacin was the most common antimicrobial therapy at discharge (68.9%) in the non–ESBL‐GNR group whereas ertapenem was the most common in the ESBL‐GNR group (44.5%). Median eGFR at discharge was 41 mL/min/1.73 m 2 in the ESBL‐GNR group and 48 mL/min/1.73 m 2 in the non–ESBL‐GNR group. Ninety‐day readmission occurred in 9 (50%) ESBL‐GNR patients and 14 (32%) non–ESBL‐GNR patients. None of the above comparisons are statistically significant ( p > 0.05). Eleven (61%) ESBL‐GNR and 2 (4%) non–ESBL‐GNR patients used outpatient parenteral antimicrobial therapy ( p < 0.001).
Conclusions
Among KTs with ESBL‐GNR bacteremia, no significant difference was detected in mortality or allograft function compared to non–ESBL‐GNR bacteremia.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, University of Alabama at Birmingham, Birmingham, USA.
- School of Nursing, University of Alabama at Birmingham, Birmingham, USA.
- Department of Medicine, University of Alabama at Birmingham, Birmingham, USA.
- Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, USA.
ORCID profiles: Madeleine S Tilley, Seth W Edwards, Matthew L Brown, Peng Li, Shikha Mehta, Jeremey Walker, Kristofer C Gutierrez
Cite
APA
Tilley, M. S., Edwards, S. W., Brown, M. L., Li, P., Mehta, S., Walker, J., & Gutierrez, K. C. (2024). Assessment of Posttransplant Bacteremia Caused by Extended‐Spectrum Beta‐Lactamase–Producing Gram‐Negative Bacteria Among Kidney Transplant Recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.15390
Vancouver
Tilley MS, Edwards SW, Brown ML, Li P, Mehta S, Walker J, et al. Assessment of Posttransplant Bacteremia Caused by Extended‐Spectrum Beta‐Lactamase–Producing Gram‐Negative Bacteria Among Kidney Transplant Recipients. Clinical Transplantation. 2024. doi:10.1111/ctr.15390
BibTeX
@article{Tilley2024,
author = {Tilley, Madeleine S and Edwards, Seth W and Brown, Matthew L and Li, Peng and Mehta, Shikha and Walker, Jeremey and Gutierrez, Kristofer C},
title = {Assessment of Posttransplant Bacteremia Caused by Extended‐Spectrum Beta‐Lactamase–Producing Gram‐Negative Bacteria Among Kidney Transplant Recipients},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15390}
}
EUVIMED